Suppression of human macrophage-mediated cytotoxicity by transgenic swine endothelial cell expression of HLA-G
Authors:
- 1 March 2015
- journal article
- Published by Elsevier in Transplant Immunology
- Vol. 32 (2) , 109-115
Abstract
No abstract availableKeywords
Funding Information
- Grant-in-Aids for Scientific Research Japan (T264619440)
- Health and Lalor Sciences Research (KH23S0120)
This publication has 25 references indexed in Scilit:
- Synthetic HLA‐G proteins for therapeutic use in transplantationThe FASEB Journal, 2013
- Complement regulation in the GalT KO eraXenotransplantation, 2010
- A homodimeric complex of HLA‐G on normal trophoblast cells modulates antigen‐presenting cells via LILRB1European Journal of Immunology, 2007
- Role for CD47-SIRPα signaling in xenograft rejection by macrophagesProceedings of the National Academy of Sciences, 2007
- Structural basis for recognition of the nonclassical MHC molecule HLA-G by the leukocyte Ig-like receptor B2 (LILRB2/LIR2/ILT4/CD85d)Proceedings of the National Academy of Sciences, 2006
- Involvement of position-147 for HLA-E expressionBiochemical and Biophysical Research Communications, 2006
- Co-effect of HLA-G1 and glycosyltransferases in reducing NK cell-mediated pig endothelial cell lysisTransplant Immunology, 2003
- EFFECTS OF TRANSFECTED COMPLEMENT REGULATORY PROTEINS, MCP, DAF, AND MCP/DAF HYBRID, ON COMPLEMENT-MEDIATED SWINE ENDOTHELIAL CELL LYSISTransplantation, 1994
- A Class I Antigen, HLA-G, Expressed in Human TrophoblastsScience, 1990
- THE MECHANISM OF DISCORDANT XENOGRAFT REJECTIONTransplantation, 1988